Doctor profile · Federal record
Dr. PAUL HAVER, M.D.
Family Medicine Physician (CMS: FAMILY PRACTICE) · ATHENS, GA
- NPI 1770578155
- Accepts Medicare
- 40 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2205 BARNETT SHOALS RD
ATHENS, GA 306053605
(706) 548-1555
fax (706) 548-1577
Credentials & registration
- NPI registered
- September 2005 — 21 yrs on file
- Profile last updated
- March 6, 2017
- Year of graduation
- 1986 — 40 yrs since
- Specialty taxonomy
- 207Q00000X — NUCC code
- State license (1)
- Georgia #031605
- Medicaid
- GA #000475329A
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1770578155. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,710
Distinct HCPCS
10
Medicare allowed
$112,399
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 440 | 188 | $120 | |
36415 |
Insertion of needle into vein for collection of blood sample | 178 | 143 | $8 | |
G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 177 | 177 | $120 | |
G0444 |
Annual depression screening, 5 to 15 minutes | 174 | 174 | $17 | |
99497 |
Advance care planning, first 30 minutes | 171 | 171 | $78 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 171 | 17 | $0 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 140 | 100 | $85 | |
83036 |
Hemoglobin a1c level | 61 | 41 | $9 | |
96372 |
Injection of drug or substance under skin or into muscle | 44 | 29 | $13 | |
81000 |
Manual urinalysis test with examination using microscope, non-automated | 35 | 28 | $4 |
In context: peer comparison
Among 12 peers in this city , average services per provider: 93. This provider delivers 18× the peer median.Open Payments
Industry payments received
All-time total
$1,385
Transactions
75
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novo Nordisk Inc | 14 | $219.94 | |
| Lilly USA, LLC | 11 | $185.54 | |
| AstraZeneca Pharmaceuticals LP | 8 | $164.16 | |
| PFIZER INC. | 11 | $149.34 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $90.37 | |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $83.60 | |
| Abbott Laboratories | 4 | $71.52 | |
| Otsuka America Pharmaceutical, Inc. | 3 | $70.37 | |
| GlaxoSmithKline, LLC. | 3 | $58.50 | |
| Amgen Inc. | 4 | $55.97 | |
| Exact Sciences Corporation | 2 | $38.21 | |
| Astellas Pharma US Inc | 2 | $37.82 | |
| ABBVIE INC. | 2 | $31.97 | |
| Corcept Therapeutics | 1 | $30.00 | |
| Novartis Pharmaceuticals Corporation | 1 | $28.90 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,736
Patients
802
Total drug cost
$28,138
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Rosuvastatin Calcium | Generic | 396 | 112 | $5,852 |
| Levothyroxine Sodium | Generic | 382 | 106 | $5,403 |
| Amlodipine Besylate | Generic | 213 | 60 | $1,371 |
| Alprazolam | Generic | 199 | 42 | $1,429 |
| Gabapentin | Generic | 178 | 37 | $2,737 |
| Escitalopram Oxalate | Generic | 169 | 35 | $2,041 |
| Tramadol Hcl | Generic | 159 | 35 | $1,087 |
| Metformin Hcl | Generic | 148 | 42 | $810 |
| Zolpidem Tartrate | Generic | 140 | 21 | $579 |
| Atorvastatin Calcium | Generic | 138 | 43 | $1,628 |